Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Takeda Pharmaceutical Q3 Core EPS ¥150.00 Down From ¥168.00 YoY, Sales ¥1.11T Up From ¥1.096T YoY

Author: Benzinga Newsdesk | February 01, 2024 02:30am

Takeda Pharmaceutical Reported Q3 Core EPS $1.07 and Sale $7.885 Billion.

Posted In: TAK